Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Prostatic adenocarcinoma with urothelial (transitional cell) carcinoma features.

Mai KT, Collins JP, Veinot JP.

Appl Immunohistochem Mol Morphol. 2002 Sep;10(3):231-6.

PMID:
12373149
2.
3.

Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.

Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA.

Am J Clin Pathol. 2000 Mar;113(3):383-8.

PMID:
10705819
4.

Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.

Osunkoya AO, Epstein JI.

Am J Surg Pathol. 2007 Sep;31(9):1323-9.

PMID:
17721186
5.

The androgen receptor revisited in urothelial carcinoma.

Birtle AJ, Freeman A, Munson P.

Histopathology. 2004 Jul;45(1):98-9. No abstract available.

PMID:
15228457
6.

Prostatic duct carcinoma with combined prostatic duct adenocarcinoma and urothelial carcinoma features: report of a case.

Pacchioni D, Casetta G, Piovano M, Fraire F, Volante M, Sapino A, Tizzani A, Bussolati G.

Int J Surg Pathol. 2004 Jul;12(3):293-7.

PMID:
15306945
7.
8.

Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases.

Martínez-Rodríguez M, Ramos D, Soriano P, Subramaniam M, Navarro S, Llombart-Bosch A.

Int J Surg Pathol. 2007 Apr;15(2):213-8.

PMID:
17478786
9.

[Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature].

Junca A, Frouin E, Irani J, Fromont G, Levillain P.

Ann Pathol. 2015 Dec;35(6):496-501. doi: 10.1016/j.annpat.2015.09.005. Epub 2015 Nov 17. Review. French.

PMID:
26597142
10.
11.

Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.

Genega EM, Hutchinson B, Reuter VE, Gaudin PB.

Mod Pathol. 2000 Nov;13(11):1186-91.

12.

Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.

Gordetsky J, Epstein JI.

Am J Surg Pathol. 2014 Jul;38(7):941-5. doi: 10.1097/PAS.0000000000000178.

PMID:
24503758
13.
15.

Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.

Ormsby AH, Haskell R, Jones D, Goldblum JR.

Mod Pathol. 2000 Jan;13(1):46-51.

16.
17.

Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.

Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI.

Am J Surg Pathol. 2007 Aug;31(8):1246-55.

PMID:
17667550
18.

Immunohistochemical differential diagnosis between urothelial carcinoma and prostate adenocarcinoma among Egyptian patients.

Sakr SA, Abdel-Wahed MM, El-Sahra DG.

Biomed Pharmacother. 2014 Jul;68(6):685-92. doi: 10.1016/j.biopha.2014.08.003. Epub 2014 Aug 22.

PMID:
25194443
19.

Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.

Chang A, Amin A, Gabrielson E, Illei P, Roden RB, Sharma R, Epstein JI.

Am J Surg Pathol. 2012 Oct;36(10):1472-6. doi: 10.1097/PAS.0b013e318260cde7.

20.

Does prostatic ductal adenocarcinoma exist?

Bock BJ, Bostwick DG.

Am J Surg Pathol. 1999 Jul;23(7):781-5.

PMID:
10403300

Supplemental Content

Support Center